MATWIN’s platform objectives
MATWIN (Maturation & Accelerating Translation With Industry) is the only French open-innovation platform specifically dedicated to oncology. MATWIN, a wholly owned subsidiary of Unicancer group (gathering all the French Comprehensive Cancer Centres) offers several actions (expertise, accelerating program, events, etc.) aiming at accelerating the development of innovative projects dedicated to the fight against cancer.
Research
Strenghten innovations’ transfer potential in partnership with the national ecosystem (canceropôles, TTOs, clusters …
Industry
Mutualize a sourcing platform of « shortlisted » early innovative projects
Patients
Contribute to accelerate treatments/ diagnostics outlooks
How to work with MATWIN ?
MATWIN in figures
applicants
projects interviewed by the board
start-up created
projects transferred
participants for meet2win
MEET2WIN : our annual partnering convention dedicated to open innovation in oncology
News
PR: MATWIN highlights about thirty innovative projects to tackle cancer
Download the press release:
PR: MATWIN and the Paris Saclay Cancer Cluster join their forces to accelerate innovation in the fight against cancer
MATWIN and the Paris Saclay Cancer Cluster join their forces to accelerate innovation in the fight against cancer. This collaboration [...]
2023 Horizon Europe call to support the EU Cancer Mission
Apply for the 2023 HorizonEU call under the EU Cancer Mission to improve cancer research, prevention, diagnostics and patients' quality [...]